Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma.

about

Search for melanoma markers in plasma and serum samples.Surgical treatment of melanoma.Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.

P2860

Q33221893-327BDC94-92E2-4EB0-9A14-471B119CDB55 Q35188550-68660B7A-2B60-4BEE-B074-3E2CF56FCA57 Q36707344-6B3B9B87-4900-419B-B802-08C64F506A08

P2860

Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma.

Item

http://www.wikidata.org/entity/Q50500281

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Serum S100 concentrations are ...... cutaneous malignant melanoma.

@en

Serum S100 concentrations are ...... cutaneous malignant melanoma.

@nl

type

Item

label

Serum S100 concentrations are ...... cutaneous malignant melanoma.

@en

Serum S100 concentrations are ...... cutaneous malignant melanoma.

@nl

prefLabel

Serum S100 concentrations are ...... cutaneous malignant melanoma.

@en

Serum S100 concentrations are ...... cutaneous malignant melanoma.

@nl

P1476

Serum S100 concentrations are ...... cutaneous malignant melanoma.

@en

P2093

Abraha H

http://www.w3.org/2001/XMLSchema#string

Acland K

http://www.w3.org/2001/XMLSchema#string

Calonje E

http://www.w3.org/2001/XMLSchema#string

Evans AV

http://www.w3.org/2001/XMLSchema#string

Healy CM

http://www.w3.org/2001/XMLSchema#string

Higgins E

http://www.w3.org/2001/XMLSchema#string

Orchard G

http://www.w3.org/2001/XMLSchema#string

Roblin P

http://www.w3.org/2001/XMLSchema#string

Russell-Jones R

http://www.w3.org/2001/XMLSchema#string

Sherwood R

http://www.w3.org/2001/XMLSchema#string

P2860

Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E

Serological markers for melanoma.

Serum S100--a marker for disease monitoring in metastatic melanoma.

The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma.

Elevated serum levels of S100 and survival in metastatic malignant melanoma

Perspectives in S-100 protein biology. Review article.

A new American Joint Committee on Cancer staging system for cutaneous melanoma.

Effect of S-100 proteins and calmodulin on Ca2+-induced disassembly of brain microtubule proteins in vitro.

P304

832-835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2133.2002.04691.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12000380

http://www.w3.org/2001/XMLSchema#string

Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma.

about

P2860

P2860

Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698